Market Tracker

05/03 4:08pm ET

Incyte Corp (NASDAQ:INCY)

72.26
Delayed Data
As of 3:53pm ET
 -2.10 / -2.82%
Today’s Change
55.00
Today|||52-Week Range
133.62
-33.37%
Year-to-Date

Today’s Trading

Previous close74.36
Today’s open73.45
Day’s range71.55 - 74.40
Volume725,887
Average volume (3 months)2,091,360
Market cap$13.6B
Dividend yield--
Data as of 3:53pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+612.74%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio2,072.3
Price/Sales26.95
Price/Book78.81

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-1.73-1.99%
PRGOPerrigo Company PLC+0.80+0.83%
VRXValeant Pharmaceutic...+3.06+9.37%
MDVNMedivation Inc-0.39-0.67%
Data as of 3:53pm ET, 05/03/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts